Lazarus R, Querton B, Corbic Ramljak I, Dewasthaly S, et al. Immunogenicity and safety of an inactivated whole-virus COVID-19 vaccine
(VLA2001) compared with the adenoviral vector vaccine ChAdOx1-S in adults in the
UK (COV-COMPARE): interim analysis of a randomised, controlled, phase 3,
immunobridging trial. Lancet Infect Dis 2022 Sep 5. pii: S1473-3099(22)00502.
PMID: 36075233